20 LATEST RESOURCES (195 INDEXED)
Limited Usefulness of Neurocognitive Functioning Indices as Predictive Markers for Treatment Response to Methylphenidate or Neurofeedback@Home in Children and Adolescents with ADHD · January 2024
Articles
Frontiers in Psychiatry
Cocaine or Methamphetamine Use During Young Adulthood Following Stimulant Use for Attention-Deficit/Hyperactivity Disorder During Adolescence · July 2023
Articles
JAMA Network Open
Methylphenidate Is More Effective to Improve Inhibitory Control and Working Memory Compared to tDCS in Children and Adolescents with Attention Deficit/Hyperactivity Disorder: A Proof-of-Concept Study · July 2023
Articles
Frontiers in Neuroscience
Perspectives of French Adolescents with ADHD and Child and Adolescent Psychiatrists Regarding Methylphenidate Use · March 2023
Articles
Scientific Reports
The Effect of Drug Use, Body Mass Index and Blood Pressure on Oxidative Stress Levels in Children and Adolescents with Attention Deficit and Hyperactivity Disorder · February 2023
Articles
Clinical Psychopharmacology and Neuroscience
Long-Term Methylphenidate Exposure and 24-Hours Blood Pressure and Left Ventricular Mass in Adolescents and Young Adults with Attention Deficit Hyperactivity Disorder · October 2022
Articles
European Neuropsychopharmacology
OROS-Methylphenidate to Reduce ADHD Symptoms in Male Prisoners Aged 16-25 Years: A RCT · July 2022
Publications (Books-Reports)
National Institute for Health and Care Research
A Systematic Review of the Use of Atomoxetine for Management of Comorbid Anxiety Disorders in Children and Adolescents with Attention-Deficit Hyperactivity Disorder · June 2022
Articles
Research in Developmental Disabilities
Withdrawing Methylphenidate in Relation to Serum Levels of Ferritin and Zinc in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder · June 2022
Articles
Journal of Psychiatric Research
Cognitive Behavioural Group Therapy as Addition to Psychoeducation and Pharmacological Treatment for Adolescents with ADHD Symptoms and Related Impairments: A Randomised Controlled Trial · June 2022
Articles
BMC Psychiatry
Effects of Methylphenidate on Somatic Symptoms and Brain Functional Connectivity in Adolescents with Attention Deficit Hyperactivity Disorder: A Pilot Study · May 2022
Articles
Clinical Psychopharmacology and Neuroscience
Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study · May 2022
Articles
Journal of Clinical Medicine
Therapeutic Drug Monitoring of Atomoxetine in Children and Adolescents with Attention-Deficit/ Hyperactivity Disorder: A Naturalistic Study · April 2022
Articles
Journal of Neural Transmission
Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD · January 2022
Articles
International Journal of Environmental Research and Public Health
Patterns of Medication Prescription among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United States · January 2022
Articles
Children
Effect of a Multilayer, Extended-Release Methylphenidate Formulation (PRC-063) on Sleep in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial Followed by a 6-Month Open-Label Follow-Up · November 2021
Articles
Journal of Child and Adolescent Psychopharmacology
Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension · November 2021
Articles
Journal of Child and Adolescent Psychopharmacology
The Management of ADHD in Children and Adolescents: Bringing Evidence to the Clinic: Perspective from the European ADHD Guidelines Group (EAGG) · October 2021
Articles
European Child and Adolescent Psychiatry
Long-Term Medication for ADHD and Development of Cognitive Functions in Children and Adolescents · August 2021
Articles
Journal of Psychiatric Research